129
Feng X#, Liu S, Wang Y, Zhang Y, Sun , Li H, Wang C, Liu Y*, Cao B*. Synergistic Activity of Colistin Combined With Auranofin Against Colistin-Resistant Gram-Negative Bacteria. Front Microbiol. 2021 Jun 25;12:676414. doi: 10.3389/fmicb.2021.676414. eCollection 2021.
130
Du S# , Wu X#, Li B#, Wang Y#, Shang L#, Huang X, Xia Y, Yu D, Lu N, Liu Z, Wang C, Liu X, Xiong Z, Zou X, Lu B, Liu Y, Zhan Q, Cao B. Clinical factors associated with composition of lung microbiota and important taxa predicting clinical prognosis in patients with severe community-acquired pneumonia. Front Med .2021 Jul 24;1-14. doi: 10.1007/s11684-021-0856-3. Online ahead of print.
131
Wang G#, Wang Q#, Wang Y#, Liu C#, Wang L#, Chen H#, Jiao T, Hu C, Lei X, Guo L, Ren L, Li M , Zhao Y, Zeng X, Zhang D, Cao B*, Wang J*. Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study. frontiersin in Immunology. published: 20 December 2021 doi: 10.3389/fimmu.2021.791348
132
Mu S#, Hu L#, Zhang Y#, Liu Y#, Cui X#, Zou X#, Wang Y, Lu B, Zhou S, Liang X, Liang C, Nick Xiao, Justin O'Grady, Shela Lee*, Cao B*. Prospective Evaluation of a Rapid Clinical Metagenomics Test for Bacterial Pneumonia. Front Cell Infect Microbiol.2021 Oct 19;11:684965. doi: 10.3389/fcimb.2021.684965. eCollection 2021.
133
Sun L#, Li L, Du S, Liu Y, Cao B*. An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of lower respiratory infections-a multicenter prospective study on ICU patients. Eur J Clin Microbiol Infect Dis. 2021 May 1. doi: 10.1007/s10096-021-04259-6. Online ahead of print.
134
Li H#, Cui X, Sun L, Deng X, Liu S, Zou X, Li B, Wang C, Wang Y, Liu Y, Lu B*, Cao B*. High concentration of Cas12a effector tolerates more mismatches on ssDNA. FASEB J. 2021 Jan;35(1):e21153. doi: 10.1096/fj.202001475R. Epub 2020 Nov 6.
135
Guo L#, Wang Y#, Kang L#, Hu Y#, Wang L#, Zhong J#, Chen H#, Ren L, Gu X, Wang G, Wang C, Dong X, Wu C, Han L, Wang Y, Fan G, Zou X, Li H, Xu J, Jin Q, Cao B*, Wang J*. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Emerg Microbes Infect. 2021 Dec;10(1):664-676. doi: 10.1080/22221751.2021.1905488.
136
Jiang R#, Han B, Dou C, Zhou F, Cao B*, Li X*. Analysis of antibiotic usage for viral community-acquired pneumonia in adults. Front Med. 2021 Feb;15(1):139-143. doi: 10.1007/s11684-019-0736-2. Epub 2020 Jun 13.
137
Shang L#, Gu X#, Du S, Wang Y, Cao B*, Wang C*, for CAP-China Network. The efficacy and safety of therapeutic lung lavage for exogenous lipoid pneumonia: A systematic review. Clin Respir J. 2021 Feb;15(2):134-146. doi: 10.1111/crj.13273. Epub 2021 Feb 2.
138
Huang L#, Gu X, Wang Y, Huang C, Bin Cao B*. Long-term effects of COVID-19 on kidney function - Authors' reply. Lancet. 2021 May 15;397(10287):1807-1808. doi: 10.1016/S0140-6736(21)00875-8.
139
Huang C#, Huang L#, Wang Y#, Li X#, Ren L#, Gu X#, Kang L#, Guo L#, Liu M#, Zhou X, Luo J, Huang Z, Tu S, Zhao, Y, Chen L, Xu D, Li Y, L C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan g, Xu J, Wang G, Wang Y, Zhang J, Wang C, Wang J*, Zhang D*, Cao B*. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan 16;397(10270):220-232; doi: 10.1016/S0140-6736(20)32656-8
140
Zhao J#, Zhang Y, Fan Y, Han J, Xiong Z, Liu X, Li B, Lu B*, Cao B*. Characterization of an NDM-5-producing hypervirulent Klebsiella pneumoniae sequence type 65 clone from a lung transplant recipient. Emerg Microbes Infect. 2021 Dec;10(1):396-399. doi: 10.1080/22221751.2021.1889932.
141
Han X#, Chen L, Wang Y, Li H, Wang H, Xing X, Zhang C, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu X*, Cao B*, CAP-China Network. Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward. Infect Drug Resist. 2021 May 18;14:1845-1853. doi: 10.2147/IDR.S302852. eCollection 2021.
142
Huang L#,Cao B*. Post-acute conditions of patients with COVID-19 not requiring hospital admission. Lancet Infect Dis. 2021 May 10;S1473-3099(21)00225-5. doi: 10.1016/S1473-3099(21)00225-5. Online ahead of print.
143
Shang L#, David Chien Lye,Cao B*. Contemporary narrative review of treatment options for COVID-19. Respirology. 2021 Aug;26(8):745-767. doi: 10.1111/resp.14106. Epub 2021 Jul 8.
144
Gu X, Cao B. In-hospital complications associated with COVID-19. Lancet. 2021 Jul 17;398(10296):188-190. doi: 10.1016/S0140-6736(21)00983-1.